RT
Healthcare & Life Sciences
Ratio Therapeutics
United Stateswww.ratiotx.com/
Ratio Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Ratio Therapeutics
Ratio Therapeutics is a startup based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Ratio Therapeutics develops targeted radiopharmaceuticals using proprietary targeting scaffolds, pharmacokinetic modulation, and chelation technology to create precision cancer therapies that combine diagnostic imaging and therapeutic radioisotopes.
Explore Ratio Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.